Jade Biosciences Stock Price, News & Analysis
JBIO
NASDAQ
Company Description
Welcome to the overview page for Jade Biosciences (JBIO), where you can find comprehensive stock information and company updates.
Explore the latest news on strategic partnerships, quarterly and annual financial results, and regulatory filings including SEC reports and insider transactions.
Visualize performance trends using the interactive price chart, and keep track of upcoming events such as earnings calls, dividend dates, and investor conferences.
Stock Performance
$—
0.00%
0.00
Last updated:
-30.67 %
Performance 1 year
$238.2M
Market Cap
32.2M
Shares outstanding
Latest News
SEC Filings
Financial Highlights
$590
Net Income (TTM)
$0.86
Diluted EPS (TTM)
$38,916
Operating Cash Flow
10.31
Current Ratio
$27,778
Operating Income
—
Revenue (TTM)
Upcoming Events
January 1, 2026 - June 30, 2026
JADE101 interim data
Interim clinical data expected for JADE101 Phase 1 trials
January 1, 2026 - April 30, 2026
JADE201 clinical entry
Planned clinical entry for JADE201 targeting systemic autoimmune diseases in H1 2026
Frequently Asked Questions
What is the current stock price of Jade Biosciences (JBIO)?
The current stock price of Jade Biosciences (JBIO) is $6.77 as of August 14, 2025.
What is the market cap of Jade Biosciences (JBIO)?
The market cap of Jade Biosciences (JBIO) is approximately 238.2M.
What is the net income of Jade Biosciences (JBIO)?
The trailing twelve months (TTM) net income of Jade Biosciences (JBIO) is $590.
What is the earnings per share (EPS) of Jade Biosciences (JBIO)?
The diluted earnings per share (EPS) of Jade Biosciences (JBIO) is $0.86 on a trailing twelve months (TTM) basis.
What is the operating cash flow of Jade Biosciences (JBIO)?
The operating cash flow of Jade Biosciences (JBIO) is $38,916.
What is the current ratio of Jade Biosciences (JBIO)?
The current ratio of Jade Biosciences (JBIO) is 10.31, indicating the company's ability to pay short-term obligations.
What is the operating income of Jade Biosciences (JBIO)?
The operating income of Jade Biosciences (JBIO) is $27,778.